Validation of ATS guidelines for FeNO to monitor eosinophillic airway inflammation

Maria Vestergaard (Copenhagen, Denmark), Maria Vestergaard, Asger Sverrild, Vibeke Backer, Celeste Porsbjerg

Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease
Session: Exhaled biomarkers in children and adults with airways disease
Session type: Poster Discussion
Number: 2084
Disease area: Airway diseases, Paediatric lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Maria Vestergaard (Copenhagen, Denmark), Maria Vestergaard, Asger Sverrild, Vibeke Backer, Celeste Porsbjerg. Validation of ATS guidelines for FeNO to monitor eosinophillic airway inflammation. Eur Respir J 2015; 46: Suppl. 59, 2084

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Further evidence that FeNO directed therapy reduces asthma exacerbations
Source: International Congress 2014 – Airway biomarkers
Year: 2014


Interaction between airway calibre and exhaled NO: Impact on asthma control assessment
Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases
Year: 2013

Small airway dysfunction and its role in pediatric asthma control assessment
Source: International Congress 2016 – Techniques and tools in paediatric asthma
Year: 2016


Weak association between exhaled nitric oxide and bronchial responsiveness in asthmatic patients
Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Year: 2013

Positive relationship between offline exhaled nitric oxide and lung clearance index in pre-school wheezers
Source: International Congress 2014 – Paediatric asthma: lung function testing and more
Year: 2014

Relation of asthma control and exhaled nitric oxide in patients with bronchial hyperresponsiveness to methacholine
Source: Annual Congress 2013 –New issues in lung function testing
Year: 2013


Validation of ATS cut-off points for FeNO in a clinical unselected population of subjects with possible asthma
Source: International Congress 2014 – Systemic and airway biomarkers
Year: 2014

Role of fractional exhaled nitric oxide(FeNO) in obstructive airway diseases in Indian population
Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease
Year: 2015


Inflammatory patterns in asthmatic children based on the measurement of alveolar nitric oxide
Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules
Year: 2013


Non-invasive markers of airway eosinophilic inflammation in pre-school children
Source: International Congress 2014 – Paediatric asthma: markers and molecules
Year: 2014

Normal values of exhaled nitric oxide at 50 mL/s – A revisit
Source: International Congress 2014 – Systemic and airway biomarkers
Year: 2014

Meta-analysis of the accuracy of screening adult asthma using exhaled nitric oxide
Source: Annual Congress 2013 –Studies of asthma in man
Year: 2013


Assessment of small airways dysfunction with impulse oscillometry, multiple flow nitric oxide and spirometry in the Wessex severe asthma cohort study
Source: International Congress 2015 – Lung function: waiting to exhale...
Year: 2015

Domiciliary diurnal variation of fractional exhaled nitric oxide (FeNO) to monitor asthma control
Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases
Year: 2013

Evaluation of fractional exhaled nitric oxide and peripheral blood eosinophil count as biomarkers in patients with refractory asthma
Source: Annual Congress 2013 –Asthma
Year: 2013


Utility and validity of NO Vario Analyser® equipment for the determination of nitric oxide in exhaled air (FeNO)
Source: International Congress 2014 – Airway biomarkers
Year: 2014


Effect of spirometry and bronchodilation test in eNO levels
Source: International Congress 2016 – The future of lung function is beginning now
Year: 2016

Alveolar nitric oxide and its role in asthma control assessment
Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules
Year: 2013


Exhaled nitric oxide and the therapeutic regimens in childhood asthma
Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules
Year: 2013

Different patterns of exhaled NO response to acute bronchodilation in asthma
Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Year: 2013